Serological markers exploration and real-world effectiveness and safety of teriflunomide in south Chinese patients with multiple sclerosis

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations

Neurological Disorder, Patient Selection, Clinical Neurology +17

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

Giulio Disanto, Christian Barro, Pascal Benkert et al. · Annals of Neurology · 2017 · 1.1K citations · Full text

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Paul O’Connor, Jerry S. Wolinsky, Christian Confavreux et al. · New England Journal of Medicine · 2011 · 965 citations · Full text

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O’Connor, Mark Freedman et al. · The Lancet Neurology · 2014 · 566 citations

Oral Teriflunomide, Neurological Disorder, Medicine +6

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

Jens Kühle, Harald Kropshofer, Dieter Haering et al. · Neurology · 2019 · 531 citations · Full text